Published in J Lab Clin Med on May 01, 1970
Leprosy. Clin Microbiol Rev (1988) 1.74
Specificity of IgG subclass antibodies in different clinical manifestations of leprosy. Clin Exp Immunol (1992) 1.13
T and B lymphocytes in patients with lepromatous leprosy. Clin Exp Immunol (1974) 0.91
Non-specific humoural immunity response in latent and tertiary syphilis. Br J Vener Dis (1972) 0.91
Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes. Immunology (1987) 0.85
Amyloid-related serum component (protein ASC) IN LEPROSY PATIENTS. Infect Immun (1975) 0.82
Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy. Immunology (1999) 0.81
Immunological problems in leprosy research. 1. Clinical and pathological spectrum of leprosy. Bull World Health Organ (1970) 0.75
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia (2011) 3.97
The functional human dihydrofolate reductase gene. J Biol Chem (1984) 3.28
Chromosomal organization of the human dihydrofolate reductase genes: dispersion, selective amplification, and a novel form of polymorphism. Proc Natl Acad Sci U S A (1984) 2.99
Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med (1987) 2.87
Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med (1995) 2.79
Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol (1971) 2.71
Pharmacodynamics of carbenicillin in hepatic and renal failure. Ann Intern Med (1970) 2.47
The evolution of immunosuppressive cell populations in experimental mycobacterial infection. J Immunol (1978) 2.19
Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother (1976) 1.94
Intronless human dihydrofolate reductase genes are derived from processed RNA molecules. Proc Natl Acad Sci U S A (1982) 1.69
Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect Immun (1988) 1.68
Disturbance of the blood T:B lymphocyte ratio in lepromatous leprosy. Clinical and immunologic correlations. N Engl J Med (1973) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. Antimicrob Agents Chemother (1987) 1.53
A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg (2001) 1.52
Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol (1997) 1.48
Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells. Infect Immun (1979) 1.45
Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem J (1988) 1.42
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Defective leukotaxis in patients with lepromatous leprosy. J Lab Clin Med (1976) 1.41
The predisposing and protective factors against dengue virus transmission by mosquito vector. Am J Epidemiol (1992) 1.36
Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies. Infect Immun (1979) 1.36
Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy. Clin Exp Immunol (1982) 1.30
Anergy and infection. Adv Intern Med (1976) 1.27
Failure of lymphocyte transformation in response to gamma-globulins in rheumatoid arthritis. Lancet (1969) 1.27
Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum. Int J Lepr Other Mycobact Dis (1981) 1.26
Histoplasmosis. Association with circulating immune complexes, eosinophilia, and mesangiopathic glomerulonephritis. Arch Intern Med (1979) 1.24
Perturbation of lymphocyte circulation in experimental murine leprosy. II. Nature of the defect. J Immunol (1976) 1.24
Perturbation of lymphocyte circulation in experimental murine leprosy. I. Description of the defect. J Immunol (1976) 1.22
An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. N Engl J Med (1972) 1.20
Leprosy: a model of immunological perturbation in chronic infection. J Infect Dis (1978) 1.18
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Purification and characterization of human recombinant interleukin-1 beta. J Biol Chem (1987) 1.16
Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun (1991) 1.16
A novel fermentation pathway in an Escherichia coli mutant producing succinic acid, acetic acid, and ethanol. Appl Biochem Biotechnol (1998) 1.15
Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy. Biochemistry (1989) 1.15
Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations. Cell Immunol (1981) 1.14
Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des (2005) 1.12
Simple assay for clindamycin in the presence of aminoglycosides. Antimicrob Agents Chemother (1974) 1.11
Haplotype analysis to determine the position of a mutation among closely linked DNA markers. Hum Mol Genet (1993) 1.11
Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys. Antimicrob Agents Chemother (1976) 1.11
Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J Immunol (1989) 1.10
Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology (1999) 1.09
Digestion of Histoplasma capsulatum yeasts by human macrophages. J Immunol (1992) 1.08
The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am Rev Respir Dis (1986) 1.07
Hemoglobin switching in sheep. Cloning and characterization of the beta A and beta-like embryonic globin genes from genomic DNA. J Biol Chem (1980) 1.07
Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections. Ann Intern Med (1970) 1.06
Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav (2003) 1.06
Medical mycology in crisis. J Lab Clin Med (1983) 1.06
The physical mapping of bacteriophage T5 transfer tRNAs. J Biol Chem (1976) 1.06
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Ther (2001) 1.06
Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J Virol (1990) 1.04
Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun (1986) 1.03
Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship. J Biol Chem (1992) 1.01
Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function. Pharmacol Biochem Behav (1994) 0.99
Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob Agents Chemother (1985) 0.99
The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience (2003) 0.97
Action of dexmedetomidine on rat locus coeruleus neurones: intracellular recording in vitro. Eur J Pharmacol (1995) 0.96
Membranous atresia of esophagus associated with pyloric stenosis. J Pediatr Surg (1987) 0.95
Clinical and pharmacological studies of ticarcillin in gram-negative infections. Antimicrob Agents Chemother (1976) 0.95
Correlation between disc displacements and locations of disc perforation in the temporomandibular joint. Dentomaxillofac Radiol (2010) 0.95
Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2. J Immunol (1985) 0.95
Fungal biodegradation of lignopolystyrene graft copolymers. Appl Environ Microbiol (1992) 0.94
Quantitative and qualitative studies of the local cellular exudative response in leprosy. J Reticuloendothel Soc (1974) 0.93
Visual and phonological pathways to the lexicon: evidence from Chinese readers. Mem Cognit (1995) 0.92
A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence? Lupus (2006) 0.92
Serological survey of antibodies to the adult T-cell leukemia virus-associated antigen (HTLV-A) in Taiwan. Int J Cancer (1985) 0.92
Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation. Br J Ophthalmol (2006) 0.92
Alcohol and smoking in relation to the prevalence of adenomatous colorectal polyps detected at sigmoidoscopy. Epidemiology (1996) 0.91
Fatal reaction to dapsone during treatment of leprosy. Ann Intern Med (1981) 0.90
Decreased suppressor cell activity in disseminated granulomatous infections. Clin Exp Immunol (1980) 0.90
Impairment of cell-mediated immune responses by infection with Mycobacterium lepraemurium. Infect Immun (1977) 0.90
Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo. J Dairy Sci (2012) 0.90
High prevalence of VanB2 vancomycin-resistant Enterococcus faecium in Taiwan. J Clin Microbiol (2001) 0.90
Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. J Immunol (1984) 0.90
Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2. Protein Eng (1997) 0.88
Immunohistologic alteration of skin and ultrastructural changes of glomerular basement membranes in leprosy. Am J Trop Med Hyg (1974) 0.88
Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice. J Immunol (1983) 0.88
Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors. J Biol Chem (1995) 0.88
Methionine and formylmethionine specific tRNAs coded by bacteriophage T5. Proc Natl Acad Sci U S A (1975) 0.88
A human dihydrofolate reductase intronless pseudogene with an Alu repetitive sequence: multiple DNA insertions at a single chromosomal site. Gene (1984) 0.88
Inflammatory myofibroblastic tumor: an unusual submucosal lesion of the stomach. Endoscopy (2011) 0.87
A statistical approach to the polymorphonuclear leukocyte bactericidal assay. J Lab Clin Med (1973) 0.87
Immunoregulation in disseminated histoplasmosis: characterization of the surface phenotype of splenic suppressor T lymphocytes. Infect Immun (1982) 0.86
Identification of a novel gene, ETX1 from Xp21.1, a candidate gene for X-linked retintis pigmentosa (RP3). Hum Mol Genet (1995) 0.86
A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. Proc Natl Acad Sci U S A (2000) 0.86
Alleviation of brain injury-induced cerebral metabolic depression by amphetamine: a cytochrome oxidase histochemistry study. Neural Plast (2000) 0.86
ZnO/Al2O3 core-shell nanorod arrays: growth, structural characterization, and luminescent properties. Nanotechnology (2009) 0.85
Granulomatous variant of chronic pigmented purpuric dermatosis: report of two cases. Br J Dermatol (2001) 0.85
A new polymorphic locus, D7S411, isolated by cloning from preparative pulse-field gels is close to the mutation causing cystic fibrosis. Genomics (1990) 0.85
Immunological aspects of fungal pathogenesis. Eur J Clin Microbiol Infect Dis (1990) 0.85
A case-control study of colorectal adenomatous polyps and consumption of foods containing partially hydrogenated oils. Cancer Epidemiol Biomarkers Prev (1999) 0.85
Morphology and intracellular localization of rice transitory yellowing virus. Virology (1971) 0.84
d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats. Brain Res (1997) 0.84
Flow microfluorometry analysis of alterations in T-lymphocyte subsets during murine listeriosis. Infect Immun (1984) 0.83
Impairment of interferon production in mice infected with Mycobacterium lepraemurium. Proc Soc Exp Biol Med (1972) 0.83
A new Vibrio species, Vibrio cincinnatiensis, causing meningitis: successful treatment in an adult. Ann Intern Med (1986) 0.83